BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37086063)

  • 81. Long-term survival associated with metastatic small cell carcinoma of the esophagus treated by chemotherapy, autologous bone marrow transplantation, and adjuvant radiation therapy.
    Huncharek M
    Cancer; 1994 Jul; 74(1):217. PubMed ID: 8004578
    [No Abstract]   [Full Text] [Related]  

  • 82. [Therapy of squamous cell carcinoma of the esophagus].
    Husemann B
    Krankenpfl J; 1984; 22(7-8):13-6. PubMed ID: 6566907
    [No Abstract]   [Full Text] [Related]  

  • 83. Pretreatment staging by endoscopic ultrasonography does not predict complete response to neoadjuvant chemoradiation in patients with esophageal carcinoma.
    Chak A
    Cancer; 2000 Mar; 88(5):1184-6. PubMed ID: 10699910
    [No Abstract]   [Full Text] [Related]  

  • 84. Oesophageal carcinoma: the view from East Birmingham.
    Matthews HR; Walker SJ
    J R Coll Surg Edinb; 1990 Oct; 35(5):279-83. PubMed ID: 2283603
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [The indications for and results of palliative treatment in patients with esophageal and cardial carcinomas].
    Peracchia A; Segalin A; Bonavina L
    Ann Ital Chir; 1993; 64(6):651-6. PubMed ID: 7521599
    [No Abstract]   [Full Text] [Related]  

  • 86. Therapy of carcinoma of the oesophagus: either attempt it not or succeed.
    Ajani JA
    Eur J Cancer; 1995; 31A(5):790-3. PubMed ID: 7640055
    [No Abstract]   [Full Text] [Related]  

  • 87. Is pathological complete response after a trimodality therapy, a predictive factor of long-term survival in locally-advanced esophageal cancer? Results of a retrospective monocentric study.
    Francoual J; Lebreton G; Bazille C; Galais MP; Dupont B; Alves A; Lubrano J; Morello R; Menahem B
    J Visc Surg; 2018 Oct; 155(5):365-374. PubMed ID: 29501383
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Preoperative hyperthermochemoradiotherapy for esophageal carcinoma.
    Nozoe T; Saeki H; Ito S; Ohga T; Kitamura K
    Surgery; 2002 Jan; 131(1 Suppl):S35-8. PubMed ID: 11821785
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The sign of Leser-Trelat associated with esophageal carcinoma.
    Chiba T; Shitomi T; Nakano O; Shimotono H; Yamada H; Fujimaki E; Orii S; Sato K; Sato S
    Am J Gastroenterol; 1996 Apr; 91(4):802-4. PubMed ID: 8677957
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Advanced esophageal cancer with an esophago-bronchial fistula successfully treated by chemoradiotherapy following esophageal bypass surgery: report of a case.
    Aoki Y; Hihara J; Sakogawa K; Taomoto J; Hamai Y; Emi M; Okada M
    Surg Today; 2012 Nov; 42(11):1088-90. PubMed ID: 22955635
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Comparative Effectiveness of Preoperative Treatment Regimens in Patients With Potentially Resectable Esophageal Cancer.
    Duff JM; Peters HC; Zingarelli W; Ben-David K; Sarosi GA; Thomas RM
    JAMA Surg; 2017 Jan; 152(1):103-105. PubMed ID: 27627680
    [No Abstract]   [Full Text] [Related]  

  • 92. [Symposium on treatment of cancer. 5. Preoperative hyperthermo-chemo-radiotherapy of esophageal carcinoma. Analysis of 20 cases].
    Sugimachi K; Kai H; Inokuchi K
    Nihon Naika Gakkai Zasshi; 1984 Nov; 73(11):1607-11. PubMed ID: 6520519
    [No Abstract]   [Full Text] [Related]  

  • 93. [Current viewpoints in the treatment of esophageal carcinoma].
    Tilanus HW; Kok TC; Eijkenboom WM
    Ned Tijdschr Geneeskd; 1993 Feb; 137(9):444-7. PubMed ID: 8446211
    [No Abstract]   [Full Text] [Related]  

  • 94. Combined-modality therapy in the treatment of local-regional esophageal cancer.
    Saltz L; Kelsen D
    Ann Oncol; 1992 Dec; 3(10):793-9. PubMed ID: 1286042
    [No Abstract]   [Full Text] [Related]  

  • 95. [Hyperthermia combined with chemotherapy and irradiation for esophageal carcinoma].
    Sugimachi K; Matsufuji H; Kai H; Kitamura M; Maekawa S
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1360-5. PubMed ID: 3729455
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Small cell carcinoma of the esophagus: a case report.
    Akagi I; Miyashita M; Makino H; Nomura T; Shimanuki K; Satake S; Hagiwara N; Uchida E
    J Nippon Med Sch; 2014; 81(2):97-100. PubMed ID: 24805096
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Adjuvant immunotherapy in resected esophageal squamous cell carcinoma: a gospel to the non-pCRs.
    Zhang Z; Sun N; He J
    Signal Transduct Target Ther; 2021 Aug; 6(1):314. PubMed ID: 34426572
    [No Abstract]   [Full Text] [Related]  

  • 98. [Interdisciplinary multi-modality therapy of advanced hypopharyngeal and proximal esophageal carcinomas].
    Fass J; Dreuw B; Korves B; von Saldern S; Andreopoulos B; Schumpelick V
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1502-4. PubMed ID: 9931925
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Combined modality therapy for esophageal cancer.
    Gamliel Z; Krasna MJ
    Curr Oncol Rep; 1999; 1(2):149-54. PubMed ID: 11122812
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Current status of preoperative treatment for carcinoma of the esophagus.
    Naunheim KS
    Semin Thorac Cardiovasc Surg; 1992 Oct; 4(4):270-5. PubMed ID: 1457565
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.